Since the 1950s, when the movement disorder tardive dyskinesia (TD) was first described, several drugs have been studied for potential effectiveness or used off-label for the treatment of TD, but none provided clear evidence of...
Read More
Are you caught up on trials on tardive dyskinesia presented on APA 2021? Test your knowledge! 1. A...
Read MoreAlthough assessing and reducing the severity of tardive dyskinesia (TD)—a persistent and potentially disabling movement disorder linked with exposure to antipsychotics and other dopamine receptor blocking agents—is crucial for...
Read MoreBy: Cecilia Peterson; Amanda Glazar; Chirag Shah; Prakash Masand; Michael Lemon Introduction: Tardive Dyskinesia (TD) refers to abnormal, involuntary, choreoathetoid movements of the tongue, lips, face, trunk, and extremities...
Read MoreHow did you do? 1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...
Read More
Chirag Shah, PharmD Head, Strategic Publications & Medical Education Medical Affairs,...
Read More
Researchers who sought to understand the evolving continuing medical education (CME) needs of...
Read MoreIn July 2020, experts participated in individual semi-structured qualitative interviews about how tardive Dyskinesia (TD) is diagnosed and treated in real-world settings. A virtual roundtable follow-up was conducted in November...
Read MoreResearchers presented the findings of cognitive behavioral therapy (CBT) benefits on anxiety, depression, and quality of life in patients with mild cognitive impairment (MCI) and dementia “Today, no reviews have analyzed...
Read MoreBy: Chirag Shah; Shereta Wiley; Sylvie Stacy; Leslie Lundt In a poster session, researchers sought to understand the evolving continuing medical education (CME) needs of psychiatrists managing patients with tardive dyskinesia...
Read MoreAs an involuntary movement disorder resulting from exposure to dopamine antagonists, tardive dyskinesia (TD) classically manifests as involuntary oro-bucco-lingual and facial dyskinesia, as well as limb, trunk, and respiratory...
Read MoreThere is growing number of treatment-refractory patients in psychiatric practice. Although evidence-based treatments may be effective in most patients, there is a significant number of psychiatric patients, who may not have an...
Read MoreData from the real-world RE-KINECT study were analyzed to better understand the impact of tardive dyskinesia (TD) on wellbeing and health state in patients who are aware of their TD. Over 200 adults with over 3 months of...
Read More
This Year’s Theme: Finding Equity Through Advances in Mind & Brain in Unsettled Times...
Read MoreA year since COVID-19 was declared a worldwide emergency, experts warn that a subsequent mental health pandemic is imminent, due to the lasting adverse impacts of stress, anxiety and isolation. This year’s Annual Meeting offers...
Read MoreFriday, April 30, 2021 11:00 a.m. – 5:30 p.m. ET Pre-Conference Expo Virtual Exhibit Gallery Product Theater Showcases Saturday, May 1, 2021 10:00 a.m. – 11:00 a.m. ET Opening Session (Plenary), Featuring Keynote Speaker Isabel...
Read MoreSchedule Friday, April 30, 2021 Noon – 1:00 p.m. ET Supported by Axsome Therapeutics Inc. [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes Roger S. McIntyre MD, FRCP Professor of...
Read MoreAPA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...
Read More
